TNET:NYSETriNet Group, Inc. Analysis
Data as of 2026-03-12 - not real-time
$36.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TriNet’s price is trading well below its longer‑term moving averages, with the short‑term average under the medium‑term and long‑term averages, signalling a bearish technical backdrop. The relative strength index sits in oversold territory while the MACD histogram has turned positive, suggesting a potential short‑term bounce toward the identified support zone.
Fundamentally, the stock appears undervalued relative to its discounted cash‑flow estimate and carries a modest dividend yield with a low payout ratio, supported by positive operating cash flow. Recent earnings beat expectations and the company announced a sizable share‑repurchase program, adding a catalyst for price support. However, revenue is contracting, margins are thin, and leverage is elevated, which tempers the upside and underscores the need for careful monitoring.
Fundamentally, the stock appears undervalued relative to its discounted cash‑flow estimate and carries a modest dividend yield with a low payout ratio, supported by positive operating cash flow. Recent earnings beat expectations and the company announced a sizable share‑repurchase program, adding a catalyst for price support. However, revenue is contracting, margins are thin, and leverage is elevated, which tempers the upside and underscores the need for careful monitoring.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- oversold RSI with emerging MACD bullish signal
- proximity to a defined support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- valuation gap to fair‑value estimate
- attractive dividend yield and low payout
- share‑repurchase program providing upside support
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- persistent revenue decline and thin margins
- high leverage relative to equity
- steady cash flow generation and dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-2.20%
Profit Margin3.14%
P/E Ratio11.4
ROE252.03%
ROA3.43%
Debt/Equity1744.44
P/B Ratio31.9
Op. Cash Flow$303.0M
Free Cash Flow$196.6M
Industry P/E29.5
Technical Analysis
TrendBearish
RSI33.1
Support$33.61
Resistance$47.42
MA 20$38.05
MA 50$50.89
MA 200$62.34
MACDBullish
VolumeDecreasing
Fear & Greed Index73.98
Valuation
Fair Value$42.95
Target Price$54.80
Upside/Downside50.47%
GradeUndervalued
TypeValue
Dividend Yield3.04%
Risk Assessment
Beta0.82
Volatility81.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.